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Background: Previous human and animal studies suggest lipin1 plays a role in myopathies, but whether lipin1 regulates
skeletal muscle regeneration remains unknown.
Results: Lipin1 regulates myoblast differentiation through cytosolic activation of ERK1/2 and a downstream effector cyclin
D3-mediated cell cycle withdrawal.
Conclusion: Lipin1 is a key regulator of myoblast differentiation.
Significance:Our study reveals a previously unknown pathway in skeletal muscle regeneration.
Lipin1, an intracellular protein, plays critical roles in control-
ling lipid synthesis and energy metabolism through its enzy-
matic activity and nuclear transcriptional functions. Several
mouse models of skeletal muscle wasting are associated with
lipin1 mutation or altered expression. Recent human studies
have suggested that children with homozygous null mutations
in the LPIN1 gene suffer from rhabdomyolysis. However, the
underlying pathophysiologic mechanism is still poorly under-
stood. In the present studywe examinedwhether lipin1 contrib-
utes to regulating muscle regeneration. We characterized the
time course of skeletal muscle regeneration in lipin1-deficient
fld mice after injury. We found that fld mice exhibited smaller
regenerated muscle fiber cross-sectional areas compared with
wild-typemice in response to injury. Our results from a series of
in vitro experiments suggest that lipin1 is up-regulated and
translocated to the nucleus during myoblast differentiation
and plays a key role in myogenesis by regulating the cytosolic
activation of ERK1/2 to form a complex and a downstream
effector cyclin D3-mediated cell cycle withdrawal. Overall,
our study reveals a previously unknown role of lipin1 in skel-
etal muscle regeneration and expands our understanding of
the cellular and molecular mechanisms underlying skeletal
muscle regeneration.
Lipin1, encoded by the Lpin1 gene, is an intracellular protein
and has dual functions as demonstrated by previous studies
(1–4). In the cytoplasm, lipin1 acts as a phosphatidic acid phos-
phohydrolase catalyzing dephosphorylation of phosphatidic
acid and is involved in triglyceride and glycerophospholipid
synthesis. In the nucleus lipin1 acts as a transcriptional co-ac-
tivator factor of PPAR in hepatocytes (3). Lipin1 translocation
between the cytoplasm and nucleus is influenced by its phos-
phorylation status (5–7). In response to insulin, lipin1 serine/
threonine sites are phosphorylated, which promotes its trans-
location out of the nucleus into the cytoplasm (7). In contrast,
disruption of 17 serine/threonine phosphorylation sites
induces exclusive nuclear localization (6).
Recently, the role of lipin1 in skeletal muscle-related diseas-
es/myopathies has gained interest (8–11). Concurrent lipin1
deficiency in the neuron/Glia-related cell adhesion molecule
(Nrcam) ofmutantmice contributed to skeletalmuscle wasting
in hindquarters and hind limb paralysis (12). Down-regulated
lipin1 mRNA expression levels were observed in dystrophin-
deficient myotubes from C57BL10 mice limb muscle (13) and
nemaline myopathies (14). Moreover, human studies have
identified a population carrying a LPIN1 gene mutation, due to
a premature stop codon insertion or as a result of a large intra-
genic deletion, which is the major cause of rhabdomyolysis
(8–10). Despite well known roles of lipin1 in lipid biosynthesis
and transcriptional regulation, the pathogenic mechanisms
leading to impaired muscle repair are still unknown. It remains
to be determined whether lipin1 plays a role in postnatal skel-
etal muscle regeneration.
Muscle regeneration is a rapid and extensive self-renewal
process relying on the presence of satellite cells. These cells are
activated and then proliferate to provide amyoblast population
that either fuses to each other to create new myofibers or fuses
to existing damaged myofibers for repair (15–18). This process
of myogenesis is regulated by the myogenic regulatory factors
including Myf5, MyoD, and MyoG. Mononucleated myoblast
proliferation is driven byMyf5 expression (19). MyoG is a mas-
ter regulator of myoblast differentiation and fusion into myofi-
bers (17).Mice lacking theMyoG gene die at birth due to severe
skeletal muscle deficiency, as myoblasts are unable to fuse into
multinucleated myofibers (20). MyoD is not only responsible
for the activation of MyoG expression in the regeneration pro-
cess but also governs cell cycle withdrawal from the G1 to G0
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phase partly through its synergistic interactions with retino-
blastoma (21–25). In the G1 phase retinoblastoma is hyperphos-
phorylated by the cyclin DCDK4/CDK6 complex, causing the
release and activation of the E2FDP transcription factor com-
plex, which in turn activates expression of the genes required
for S-phase progression (26).
The aim of this study is to investigate the role of lipin1 in
skeletal muscle regeneration. We employed a mouse regenera-
tion model induced by BaCl2 injection and compared the pro-
cess of regeneration between lipin1-deficient (fatty liver dystro-
phy (fld)2) mice with their wild-type (WT) littermates. We
evaluated the expression of the myogenic transcription factors
and proteins involved in cell cycle regulation and identified a
lipin1-associated regeneration pathway that was further veri-
fied in lipin1-depleted myoblasts and lipin1-deficient primary
myoblasts. We suggest that this new observation provides new
insights into the role of lipin1 in the skeletal muscle regenera-
tion process.
Experimental Procedures
BaCl2 Induced Muscle Injury Model—Age and gender
matched lipin1-deficient fldmice and their littermates (around
4months of age) were purchased fromThe Jackson Laboratory.
Protocols and procedures conformed to current United States
Public Health Service policies and were approved by the Insti-
tutional Animal Care and Use Committee at the University of
Kentucky.
Induction of BaCl2-inducedmuscle injurywas undertaken by
injecting around 50 l (adjusted by their body weight) of 1.2%
BaCl2 solution intramuscularly into the tibialis anterior (TA)
muscles of adult mice using a Hamilton syringe and 27-gauge
needle. Contralateral TA muscles injected with phosphate-
buffered saline (PBS) only served as uninjured controls. Injured
and uninjured muscles were then harvested at day 0 and post
mortem at 3, 5, 7, or 14 days after injury (n  4–8 mice) and
processed for immunohistochemistry, mRNA, or protein
analysis.
Histology and Immunohistochemistry in Muscle Cryosections—
TA muscles were embedded in optimal cutting temperature
compound, immediately frozen in isopentane cooled in liquid
nitrogen, and stored at80 °C until analysis. Sections of 10mm
were cut and collected from the mid-belly muscles and stained
with hematoxylin/eosin (H&E, Sigma) using standard proce-
dures (27). Immunohistochemistry of muscle cryosections was
performed with the following antibodies: anti-MyHC (myosin
heavy chain, F1.652), anti-mf20 (Developmental Studies
Hybridoma Bank), and laminin (Abcam). Labeling of cryosec-
tions with mouse monoclonal primary antibodies was per-
formed using the peroxidase or fluorescein M.O.M kit staining
(Vector Laboratories) according to the manufacturer’s instruc-
tions. Double immunostaining was performed by sequential
addition of each primary and secondary antibody using appro-
priate positive and negative controls. Sections were air-dried,
fixed on 4% paraformaldehyde, washed with PBS, and incu-
bated with primary antibodies according to the manufacturer’s
instructions after blocking for 1 h at room temperature with 1%
BSA. Subsequently, the slides were washed by PBS and incu-
bated with appropriate secondary antibodies conjugated with
Alexa Fluor 488 or 555 (Invitrogen), and nuclei were stained
with DAPI (Invitrogen). After washing, tissue sections were
mounted.
Microscope, Image Processing, and Morphometric Analysis—
Bright-field images were acquired with a microscope (Nikon
eclipse 80i) coupled with a camera (Nikon DXM 1200F) using
Nikon ACT1 (Version 2.63) or Metamorph software (Molecu-
lar Devices). The objectives used were Plan Fluor 20 0.50 or
Plan Fluor 40 1.30 oil (Nikon). Fluorescentmicrographswere
taken with a confocal microscope (Nikon Eclipse TE2000-E)
using Nikon NIS Elements software (Carl Zeiss). Lenses used
with the confocal microscope were either CFI Plan Fluor 40
Oil or CFI Plan Fluor DLL 20 (Nikon). All digital microscopic
images were acquired at room temperature.
Myofiber cross-sectional areas in injured TA muscle were
quantified via manual masking using Nikon NIS Elements soft-
ware based on laminin staining in 40 fields. A minimum of
400 myofibers and three sections were analyzed per biological
replica. To examine the efficiency of myoblast differentiation, a
fusion index (FI) was calculated as the number of nuclei present
in myotubes over the total number of nuclei present in the
observed field. Data were selected from 10 different randomly
chosen microscopic fields.
Cell Culture—C2C12 mouse myoblasts were grown to con-
fluency under 5% CO2 at 37 °C in growth medium, DMEM
medium (Gibco) supplemented with 10% (v/v) fetal bovine
serum (FBS) (Gibco), and penicillin-streptomycin (100 mg/ml,
100 units/ml) (Gibco). Todifferentiate themyoblasts, theywere
then switched to differentiation medium containing DMEM
supplemented with 2% horse serum (v/v) (Gibco) and penicil-
lin-streptomycin (100 mg/ml, 100 units/ml) for 4 days. Adeno-
viruses expressing short hairpin RNA to knockdown lipin1
(shLpin1) and control shLacZ were generous gifts from Dr.
Thurl Harris (University of Virginia). For knockdown of lipin1
expression, C2C12 myoblasts were infected with shLpin1 and
shLacZ control in growth medium containing 8 g/ml Poly-
brene for 24 h. The medium was then replaced with DMEM
supplementedwith 10%FBS. Themyoblasts were incubated for
an additional 24 h until they were just confluent.
Primary myoblasts were isolated from fld and WT mice (4
weeks of age) according to Yaffe and Saxel (28) with modifica-
tions. Briefly, hind limb muscles were dissected and minced
into pieces. Cells were dissociated in 20 ml of 0.25% trypsin, 1
mMEDTA at 37 °C for 2 h and filtered through an 85-mmnylon
mesh filter (Spectrum, Houston, TX). Dissociated single cells
were washed in PBS (Gibco/Invitrogen) and plated in collagen-
coated culture plateswith F-10-based primarymyoblast growth
medium (Ham’s F-10 nutrientmixture containing 20% fetal calf
serum, 2.5 ng/ml basic fibroblast growth factor (Promega
Corp.)), streptomycin, and penicillin and incubated at 37 °C in
5% CO2. Differentiation of myoblasts into myotubes was initi-
ated at 90% confluence by cultivation in differentiation
medium (DMEM, 5% horse serum) for up to 6 days.
When required, ERK phosphorylation inhibitor (100 M
U0126) was added in the differentiation medium. To analyze
2 The abbreviations used are: fld, fatty liver dystrophy; TA, tibialis anterior; FI,
fusion index; EGFP, enhanced GFP.
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whether cyclin D acts as a downstream target of ERK, C2C12
myoblasts were incubated with the differentiation medium in
the presence of an inhibitor for 4 days. To induce endogenous
lipin1 nuclear accumulation, C2C12 myoblasts were treated
with 150 nM Torin-1 for 24 h.
Western Blot—Cells were lysed using a protein lysis buffer
containing 1% Nonidet P-40, 150 mM NaCl, 20 mM Tris-HCl,
and protease inhibitor mixture. The protein expression levels
were examined by incubation with Myf5 (1/500; Santa Cruz
Biotechnology), MyoG (1/200; BD Biosciences), MyoD (1/300;
Santa Cruz), ERK, P-ERK, cyclin D1, cyclin D3, CDK4, CDK6
(1/1000; Cell Signaling Technology), and -tubulin (1/1000;
Sigma) primary antibodies followed by incubation with goat
anti-mouse IgG and goat anti-rabbit IgG IR Dye 680 or 800
(LI-COR) secondary antibodies.
Immunoprecipitation—C2C12 myoblasts were co-trans-
fected with HA-lipin1 together with EGFP-ERK2. 24 h after
transfection, cells were immunoprecipitated with either mouse
anti-GFP or rabbit anti-HA antibody. The interaction between
lipin1 and ERK was determined by Western blot using rabbit
an-HA or mouse anti-GFP antibody. EGFP-ERK2 plasmid was
obtained from Addgene (plasmid #40777).
Statistical Analysis—All data are presented as the means 
S.E. Student’s t test (unpaired and two tailed) or one-way anal-
ysis of variance was used to determine the statistical signifi-
cance of individual datasets. Differences were considered
significant for p 0.05 and very significant for p 0.01.
Results
Lipin1-deficient fld Mice Exhibit Impaired Skeletal Muscle
Regeneration Characterized by Smaller Muscle Fiber Cross-sec-
tional Area and Reduced Muscle Mass—We employed a BaCl2
injury model with the lipin1deficient (fld) mice to investigate
the role of lipin1 in skeletal muscle regeneration. In both wild-
type and fld groups, 50 l (adjusted by body weight) of 1.2%
BaCl2 in PBS was injected into one TA muscle, and PBS only
was injected into the contralateral TA muscle as a control (Fig.
1A). H&E staining and immunostainingwith antibodies against
laminin and embryonic myosin heavy chain were employed to
examine the effect of lipin1 deficiency on muscle regeneration
in the TA muscle at days 0, 3, 5, 7, and 14 after injury. Before
injury, no significant histological defects were observed in the
TA muscle of fldmice (Fig. 1B). Extensive myofiber damage in
bothWTand lipin1-deficient TAmuscle was observed at day 3.
Five days after injury, regenerationwas evident in bothWT and
lipin1-deficient muscles with the presence of newly formed
myotubes containing central nuclei, which is a hallmark of
regeneration. By day 14 after injury, the overall tissue architec-
ture was restored in wild-type mice indicating a complete
regeneration. In contrast, although the muscle in fld mice did
initiate regeneration, the persistence of small myofibers
expressing embryonicmyosin heavy chain at day 14 after injury
suggested that regeneration of new myofibers was still under
way (Fig. 1B). Lipin1-deficient fld mice showed significantly
reducedmeanmyofiber cross-sectional area of 1254m2 com-
pared with 1790 m2 in wild-type TA muscles injected with
BaCl2. In contrast, PBS injection alone into TAmuscles had no
effect on myofiber cross-sectional area (Fig. 1C).
Lipin1 Regulates Skeletal Muscle Regeneration by Mediating
ERK Phosphorylation and Cyclin DCDK6 Complex Expression
in Vivo—Myogenic regulatory factors including myoD and
myoG are master regulators for the commitment of myogenic
precursor cells and the terminal differentiation of myoblasts
(17, 29). Western blot analysis showed up-regulated levels of
myoD and myoG at day 3 after injury in both WT and lipin1-
deficient muscle (Fig. 2). Their expression levels then rapidly
decreased and by day 7 had returned back to the baseline. Com-
pared with WT mice, however, myoD and myoG expression
levels were suppressed by 60 and 86%, respectively, in the TA
muscles of fldmice at day 3.
To examine the mechanisms underlying defective regenera-
tion in lipin1-deficient skeletal muscle, we also analyzed the
protein expression levels of MAPK and cyclin D complexes.
These proteins have been shown to be important regulators for
myoblast differentiation and myoblast cell cycle withdrawal
(30–32). As shown in Fig. 3, although total ERK1/2 expression
FIGURE 1. Lipin1-deficient fld mice exhibit impaired skeletal muscle
regeneration characterized by smaller muscle fiber cross-sectional area
and reduced muscle mass. A, schematic representation of experimental
procedures to induce skeletal muscle regeneration. To induce acute skeletal
muscle injury, 1.2% BaCl2 solution or PBS was injected into the TA muscle of
each mouse. Injured and uninjured muscles were harvested at 0 day (before
injury) and post mortem at 3, 5, 7, or 14 days after injury. B, H&E staining and
immunostainingwith antibodies against embryonicmyosin heavy chain and
laminin of uninjured TAmuscles (day 0) and injured TAmuscles harvested at
day 3, 5, 7, and 14 after injury. Bars, 100 m. C, quantification of reduced
myofiber area at 14 days after BaCl2 injury are shown; mean cross-sectional
area forWTmyofibers is 1790m2, and fldmyofibers is 1254m2 (p 0.001).
All values are the means S.E. A minimum of 500 myofibers and 3 sections
were analyzed for three mice per genotype.
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was not altered between fld and WT mice, a lower phosphoryla-
tion of ERK1/2 was detected in the TAmuscles of fldmice. Den-
sitometric analysis indicated a respective reduction of 55 and 48%
ERK1/2 phosphorylation at days 3 and 5 after injury. As indicated
in Fig. 3, cyclin D1, D3, CDK4, and CDK6 expression levels were
markedly increased at day 3 after injury and rapidly decreased to
almost baseline levels at day 14.However, comparedwith the con-
trol group, cyclinD1,D3,CDK4, andCDK6 levelswere reducedby
71, 59, 54, and 78%, respectively, in fldmuscle at day 3. These data
suggest that lipin1 regulates skeletalmuscle regenerationbymedi-
ating ERK phosphorylation and cyclin DCDK complex-mediated
cell cycle withdrawal.
Lipin1 Is Required for Myoblast Differentiation and Lipin1-
deficient Myoblasts Had Reduced Capacity for Differentiation
in Vitro—To examine the role of lipin1 in myoblast differenti-
ation, C2C12 myoblasts were used to measure lipin1 expres-
sion. Compared with day 0, lipin1mRNA (data not shown) and
protein expression levels (Fig. 3A) were significantly enhanced
at day 4 after differentiation treatment, suggesting that lipin1 is
required for myoblast differentiation. This is consistent with a
previous study showing increased lipin1 mRNA expression in
primary human myoblasts from skeletal muscle biopsies after
differentiation treatment (33). Interestingly, we also observed
that lipin1 exhibited enhanced nuclear redistribution at day 4
after differentiation treatment (Fig. 3B). These data indicate
that lipin1 is required for myoblast differentiation, and lipin1
nuclear function could be critical for myoblast differentiation.
To test whether lipin1 deficiency could affect myogenic dif-
ferentiation, C2C12 myoblasts were infected with adenovirus
for knockdown of lipin1 expression (shLpin1). Differentiation
was examined at days 0, 2, and 4 after differentiation treatment,
and the myoblasts were shifted from growth medium to differ-
entiation medium when reaching confluence. A severe lack of
multinucleated myotube formation and enhanced mononu-
cleated myoblasts were evident in shLpin1-treated myo-
blasts compared with shLacZ control-treated myoblasts,
suggesting that lipin1 plays a critical role in myoblast differ-
entiation (Fig. 4A). A calculation of the FI (i.e. percentage of
nuclei found in myosin heavy chain-positive cells) revealed
that the lipin1 siRNA-treated myotubes had a significantly
reduced FI of 23% compared with 52% of the control
siRNA-treated myotubes (Fig. 4B). ERK1/2 phosphorylation
and cyclin D3 signaling pathways were suppressed at day 4
after differentiation treatment in lipin1-depleted C2C12
myoblasts (Fig. 4, C and D).
Because the C2C12 cell line may behave differently, we pre-
pared primary myoblasts from the hind limbmuscles of fld and
WT mice and induced differentiation. The protein expression
levels of myogenic factors and cell cycle regulators were exam-
ined by Western blot at days 0, 2, 4, and 6 after differentiation
treatment. Compared with wild-type controls, ERK1/2 phos-
phorylation and cyclin D3 expression levels were suppressed
at day 6 after differentiation treatment in differentiated fld
myotubes, which is consistent with what we observed in
C2C12 myotubes (Fig. 4E). Moreover, these results match
FIGURE 2. Lipin1 deficiency leads to impaired myogenic differentiation and reduced cyclin DCDK4/CDK6 complex expression during regenerative
myogenesis. A, the expression of myogenic factors and cell cycle regulators was detected byWestern blot at days 0, 3, 5, and 7 after injury in TAmuscle of fld
andWTmice.B, protein expression levels of fldTAmuscles at day 3 in response tomuscle injurywerequantifiedbydensitometry andexpressedas -fold change
of WT controls. Data are representative of three independent experiments.*, p 0.05; **, p 0.01.
FIGURE 3.Nuclear translocation of Lipin1 is required formyoblast differ-
entiation. Total cell lysates or cytoplasmic andnuclear protein fractions from
differentiatedC2C12were collected at 0 and4days after differentiation treat-
ment (DT). A, the expression levels of endogenous lipin1 were measured by
Western blot. Loading control forwhole cell protein is-tubulin, for cytoplas-
mic protein is GAPDH, and for nuclear protein is histone H3. B, densitometry
quantification of lipin1 expression at DT4 was quantified and expressed as
-fold change over lipin1 expression at DT0. Data are representative of three
independent experiments. **, p 0.01.
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those found in vivo and confirm that lipin1 is essential for
effective differentiation during the early stages of myogen-
esis. Our data are in agreement with previous studies that
ERK2 and cyclin D3 are critical for myoblast terminal differ-
entiation (30, 31).
Cyclin D Is a Downstream Target of the ERK Pathway—In
both muscle tissues, differentiated C2C12 myoblasts and pri-
mary myoblasts, we observed a reduction in ERK phosphoryla-
tion and cyclin D3 expression. We thus tested whether cyclin
D3 might function as a downstream target of the ERK pathway
in myoblast differentiation. C2C12 myoblasts were induced to
differentiate in the presence or absence of the ERK phosphor-
ylation inhibitor U0126. In the absence of U0126, C2C12 myo-
blasts became elongated by day 4 in differentiation medium
(Fig. 5A). In contrast, U0126-treated myoblasts remained
mononuclearwith very fewmultinucleatedmyotubes. As antic-
ipated, Western blot results showed that ERK phosphorylation
was inhibited (Fig. 5B). U0126 treatment reduced the expres-
FIGURE 4. Suppression of lipin1 expression suppresses myoblast differentiation. C2C12 myoblasts were infected with adenovirus to knockdown lipin1
(shLpin1) or control shLacZbefore differentiation.A, cellswere fixed and stained formf20 andDAPI (bars, 50m). B, fusion indexwas determinedby counting
the percentage of nuclei within mf20myotubes over total nuclei within five randomly selected fields per sample. C, immunoblots show lipin1 deficiency
induces decreased myogenin and (MyoG) cyclin D, and CDK4/CDK6 expression 4 days after the induction of myoblast differentiation. D, densitometry quan-
tification of protein expression in differentiated cells treated with shLpin1 versus control ( shLacZ). E, protein expression levels of myogenic differentiation
markers and cell cycle markers in differentiated primary myoblasts isolated fromWT or fld mice. *, p 0.05; **, p 0.01.
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sion of myoD and myoG. Consistent with what we observed in
the in vitro and in vivo studies, U0126 also decreased cyclin D3,
cyclin D1, CDK4, and CDK6 expression, suggesting that cyclin
D functions as a downstream target of ERK.
Lipin1 and Lipin1-activated ERK in Cytosol Undergo
Enhanced Nuclear Translocation during Myoblast Differenti-
ation—Dynamic subcellular translocation of many regulatory
proteins is critical to induce transcription and regulates many
intracellular processes including proliferation, differentiation,
development, and survival. Upon activation, ERKs translocate
from the cytoplasm to the nucleus (34). Lipin1 is continuously
trafficked between the nucleus and cytoplasm to perform its
enzymatic activity and nuclear functions (1, 4, 6, 7, 35, 36). The
translocation of lipin1 within the cells is closely associated with
its phosphorylation status. To examine how lipin1 activates
ERK, we measured the cytosolic and nuclear distribution of
lipin1 and phosphorylated ERK during the differentiation pro-
cess. We found that ERK phosphorylation increased at day 2
after differentiation, suggesting that ERK was activated at the
early stages of myoblast differentiation. From day 2 to day 6
after differentiation, the distribution of both lipin1 and phos-
phorylated ERK was increased in the nucleus and decreased in
the cytosol. If lipin1 activates ERK in the nucleus we would not
expect the concurrent decrease in lipin1 and phospho-ERK
expression in the cytosol. Therefore, our data suggest that
lipin1 activates ERK in the cytosol, and during myoblast differ-
entiation both lipin1 and ERK exhibit enhanced nuclear trans-
location (Fig. 6A). To further examine whether ERK phosphor-
ylation is regulated by lipin1 dephosphorylation, we transfected
C2C12myoblasts with either lipin1 9A, 17XACA, or lipin1WT
and monitored the ERK phosphorylation by Western blot.
Lipin1 9A contains alanine substitutions of all contiguous basic
residues within a polybasic motif of lipin1 sequence (4) and is
predominantly localized in the cytoplasm, whereas 17XACA, a
mutation where the serine and threonine residues are replaced
by alanines at 17 of the 19 phosphorylation sites in lipin1, was
mainly localized in the nucleus (Fig. 6B). Interestingly, we
found that lipin1 mutants localized to the nucleus were more
able to induce ERK phosphorylation than in the cytoplasm (Fig.
6C). To further test this finding, C2C12 cells were treated with
Torin-1, which is an mTOR inhibitor and has been shown to
cause a complete redistribution of lipin1 from the cytoplasm to
the nucleus (6). Consistent with Peterson et al. (6), immuno-
staining for lipin1 revealed that endogenous lipin1 in C2C12
myoblasts was found primarily within the cytosol, whereas
treatmentwith Torin-1 caused a dramatic re-localization to the
nucleus (Fig. 6D). Additionally, we observed that Torin-1 treat-
ment enhanced ERK1/2 phosphorylation by 3.6-fold from three
independent experiments (Fig. 6E). Cyclin D3 expression also
increased.
The correlation of lipin1 and ERK in cellular compartments
raises a question about whether the two proteins translocate to
the nucleus as a complex. To answer that, we co-transfected
myoblasts withHA-tagged lipin1 and EGFP-tagged ERK2. Sub-
cellular localization of HA-lipin1 and EGFP-ERK2 was exam-
ined by indirect immunofluorescence microscopy with anti-
bodies against anti-HA and anti-GFP (Fig. 6G). Both lipin1 and
ERK2weremainly localized in cytoplasmandpartially localized
in nucleus. We also measured the interaction of lipin1 and
ERK2 by protein immunoprecipitation using either anti-
GFP or anti-HA antibody. The interaction between lipin1
and ERK2 was determined byWestern blot using anti-HA or
anti-GFP antibody.We found that by pulldown of either ERK
or lipin1, we detected lipin1 or ERK2, respectively, suggest-
ing that lipin1 and ERK may translocate into the nucleus by
forming a complex (Fig. 6F). These data suggest that lipin1
activates ERK in the cytoplasm, and the two are combined to
form a nuclear translocation complex that up-regulates
cyclin D3 expression.
FIGURE5.CyclinDcomplex is thedownstreamtargetof ERK.C2C12 cellswere induced todifferentiation in thepresenceor absenceof ERKphosphorylation
inhibitor 10 M U0126 for 48 h. A, 4 days after differentiation, cells were fixed and stained with mf20 and DAPI (bars, 50 m). B, cell lysate was harvested, and
protein expression was measured by Western blot. NT, non-transfected cells.
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Discussion
This study was designed to investigate the role of lipin1 in
skeletal muscle regeneration. For this purpose we employed an
in vivomodel of skeletalmuscle regeneration and characterized
the time course of regeneration in lipin1-deficient fldmice after
muscle injury. We evaluated the consequence of lipin1 defi-
ciency in skeletal muscle regeneration and explored the signal-
ing pathway bywhich lipin1 regulates the regeneration process.
We then performed a series of in vitro experiments to mecha-
nistically define the role of lipin1 in myogenesis.
In both animal studies, primary myoblasts and C2C12 myo-
blasts, we demonstrated that lipin1 plays an important role in
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skeletal muscle regeneration and implicated the regulation of
ERK activity and expression of the cyclin D complex. This is
consistent with previous observations that cyclin D3 knock-out
mice exhibited decreased myofiber size at 21 days of regenera-
tion and that cyclin D3 deficiency was associated with reduced
proliferative capacity and impaired G1/S progression (31, 37,
38). In contrast, cyclin D3 overexpression promotes myogenic
differentiation as demonstrated by increasedMyoD andMyoG
expression (37). Unlike cyclin D3, cyclin D1CDK4 activity is
focused on myoblast proliferation and is reported to suppress
skeletal muscle differentiation by blocking the activity of the
MEF2 family of transcriptional regulators (39, 40).
Down-regulation of cyclin D3 due to lipin1 deficiency after
muscle injury is consistent with impaired myoblast prolifera-
tion. However, the mechanism driving these effects on myo-
blast proliferation and differentiation is unclear but is likely
more complex than what we present. Overall, lipin1 deficiency
significantly suppressed MyoD and MyoG expression during
regeneration, suggesting that lipin1 deficiency affected both the
skeletal muscle proliferation and differentiation process.
In skeletal muscle myoblasts, we verified that lipin1 deple-
tion suppressed skeletal muscle regeneration through inhibi-
tion of ERK phosphorylation and cyclin D3 expression. Knock-
down of lipin1 expression inhibits myoblast differentiation
characterized by increased mononuclear myoblast accumula-
tion anddecreasedmyoblast fusion. Furthermore,with the ERK
inhibitor, U0126 treatment resulted in impaired myogenesis
and down-regulation of cyclin D3, suggesting that cyclin D3
acts as a downstream target of ERK during myogenesis. Con-
sistent with what we observed, ERK1/2 is required formyoblast
terminal differentiation and multinucleated muscle fiber for-
mation (30). Activation of ERK signaling occurs at early stages
of muscle regeneration (42, 43) and in wound repair (43, 44),
suggesting that ERK phosphorylation has some beneficial
effects. Phosphatidic acid accumulation in peripheral nerves of
lipin1-deficient fld mice increases ERK1/2 activation, mediat-
ing Schwann cell dedifferentiation and proliferation (45). How-
ever, although lipin1-deficient TA muscles have increased
phosphatidic acid levels due to the lack of phosphatidic acid
phosphatase activity, the baseline levels of phosphorylated ERK
did not increase in fld mice compared with WT mice (Fig. 3).
Similarly, Kok et al. (46) did not find significant differences in
ERK1/2 phosphorylation in fld hearts, suggesting that the effect
of phosphatidic acid on ERK phosphorylation may be tissue-
specific. ERK1/2 is required for the transcriptional activation of
D-type cyclins and plays a fundamental role in the G0/G1 to the
S phase transition. ERK1/2 phosphorylation induces c-Myc,
which promotes the transcriptional activation ofD-type cyclins
(47, 48). Sustained ERK activation results in c-Fos, Fra-1, Fra-2,
c-Jun, and JunB accumulation, which stabilizes these transcrip-
tion factors, enabling the activation of cyclin D expression sev-
eral hours after stimulation (49, 50). ERK nuclear influx causes
the immediate dislodgement of retinoblastoma from its associ-
ation to laminA, triggering cell cycle entry (51). All these results
unveil that cyclin D3 is the downstream target of ERK1/2.
We demonstrated that lipin1 promotes ERK1/2 phosphory-
lation, the two form a complex, and the nuclear translocation of
this complex is required during skeletal muscle regeneration.
This suggests that lipin1 activates ERK in the cytosol, and dur-
ing myoblast differentiation both lipin1 and ERK translocate to
the nucleus. However, we do not exclude the possibility that
dephosphorylated lipin1 may also induce ERK phosphoryla-
tion, as nuclear localization of the lipin1 mutant (17XACA)
promotes ERK1/2 phosphorylation and cyclin D3 expression.
Furthermore, we verified the impact of nuclear lipin1 on ERK
activation using the mTOR inhibitor, Torin-1, to increase
lipin1 nuclear accumulation in C2C12muscle cells. Lipin1 pro-
tein, which predominantly resides in the cytosol, also exhibited
nuclear localization. Lipin1 nuclear entry could be regulated by
the nuclear localization sequence (4) or dephosphorylation (6,
7). Recent studies suggest that lipin1 is dephosphorylated in
response to oleic acid or epinephrine (7), CTDNEP1NEP1-R1
complex (52), and serine/threonine protein phosphatase-1 cat-
alytic subunit (PP1c) (53) in vitro, suggesting that skeletal mus-
cle regeneration capability could be improved by increasing
lipin1nuclear distribution.
Previous studies have demonstrated that ERK1/2 is activated
by a diverse array of transmembrane receptors usually viaGTP-
loading of Ras isoforms (54) or the activation of secondmessen-
ger kinases such as protein kinase C (55). Activated Raf kinases
phosphorylate two serine residues in the activation segment of
MEK1/2. Activated MEK1/2, in turn, phosphorylates ERK1/2
on threonine and tyrosine residues (56). In our study we mea-
sured MEK and pMEK expression with unexpected results.
Moreover, the Raf/MEK1/ERK1/2 pathway has been reported
to inhibit myogenesis through cytoplasmic retention of MEF2
(41), whereas lipin1-induced ERK1/2 phosphorylation pro-
motes myogenesis. Collectively, this suggests that lipin1 is a
unique and important regulator for ERK1/2 activation during
skeletal muscle regeneration. However, further studies are
FIGURE 6. Lipin1 and lipin1-activated ERK in cytosol undergo enhanced nuclear translocation during myoblast differentiation. A, C2C12 myoblasts
were induced to differentiation for 6 days in differentiation medium containing 2% horse serum. Proteins from cytosol and nuclear fractions were separated
frommyoblasts (day 0), or differentiated myotubes were collected at days 2, 4, and 6 after differentiation treatment. Protein expression levels of lipin1, total
ERK, and phosphorylated ERK were examined in the cytosol and nuclear fractions. GAPDH and histone were used as loading controls for cytosol and nuclear
proteins, respectively. C2C12 cells were transfected with lipin1 mutants including 9A (cytoplasmic), 17XACA (nucleus), and lipin1 WT (both cytoplasmic and
nucleus)withdifferingnucleo-cytoplasmicdistributions. 24h after transfection, cellswere fixed, and subcellular localizationof 9A, 17XACA, and lipin1WTwere
examinedbyanti-HAantibody (red) andDAPI (blue) (bars, 20m) (B), or cell lysatewasharvested, andERK1/2, phosphorylatedERK1/2, andcyclinD3expression
levels were identified by Western blot (C). Non-transfected cells (NT) were used as a negative control. To examine the effect of the nuclear accumulation of
endogenous lipin1 on ERK1/2 phosphorylation, C2C12 cells were treated with 250 nM Torin-1 for 24 h. Cells were fixed, endogenous lipin1 expression was
determined by anti-lipin1 antibody (red), and nuclei were identified by DAPI (blue) (bars, 50 m) (D), or cell lysate was harvested, and ERK1/2, P-ERK1/2, and
cyclin D3 expression levels were identified byWestern blot (E). Immunoblots are from one of five independent experiments. F, lipin1may interact with ERK by
forming a complex during nucleus translocation. C2C12 myoblasts were transfected with HA-lipin1 and EGFP-ERK2 for 48 h. Subcellular localization of lipin1
and ERK2 was examined by immunostaining with anti-HA and anti-GFP antibodies. IP, immunoprecipitation;WB, Western blot. G, after transfection, the cell
lysates were subjected to immunoprecipitation with mouse anti-GFP or rabbit-HA antibody. The immunoprecipitates were then immunoblotted with rabbit
anti-HA or mouse anti-GFP antibody. Cell lysates were also immunoblotted with anti-GFP and anti-HA antibodies.
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needed to examine whether the effect of lipin1 on ERK activa-
tion is through direct interaction with lipin1 or indirectly
through adaptor proteins.
In this study we characterized the role of lipin1 in skeletal
muscle regeneration in response to acute injury. Although skel-
etal muscle regeneration mimics a developmental process, the
actual role of lipin1 in skeletal muscle development remains to
be explored. Cyclin D3 plays a cell-autonomous and non-re-
dundant function in regulating the satellite cell pool involved in
proliferation, differentiation, and self-renewal (31). Because
lipin1 deficiency suppresses cyclin D3 expression, it would be
important to evaluate this effect on satellite cell population and
function.
In conclusion, these results reveal a previously unknown role
of lipin1 in muscle regeneration in addition to its well known
functions as a phosphatidic acid phosphatase enzyme and a
transcriptional co-regulator. In response to injury, lipin1 is up-
regulated and activates ERK in the cytoplasm to form a com-
plex, which subsequently translocates to the nucleus during
myoblast differentiation to regulate the downstream effector
cyclin D3-mediated cell cycle withdrawal (Fig. 7). These results
significantly expand our understanding of skeletal muscle
regeneration and provide insight into the complicated patho-
physiology of muscle diseases.
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